Synergistic RNA therapy for scar reduction: co-delivery mRNA and siRNA attenuates MDA5/RIG-I activation to enhance anti-fibrotic efficacy.

Wang L, Yuan H, Mou Y, Zhang K, Zhou T, Huang X

Open source

DOI
10.1016/j.jconrel.2026.115347
Published
2026 Sep 10
Container
Journal of controlled release : official journal of the Controlled Release Society
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jconrel.2026.115347,
  title = {Synergistic RNA therapy for scar reduction: co-delivery mRNA and siRNA attenuates MDA5/RIG-I activation to enhance anti-fibrotic efficacy.},
  author = {Wang L and Yuan H and Mou Y and Zhang K and Zhou T and Huang X},
  year = {2026},
  journal = {Journal of controlled release : official journal of the Controlled Release Society},
  doi = {10.1016/j.jconrel.2026.115347},
  url = {https://doi.org/10.1016/j.jconrel.2026.115347}
}

RIS

TY  - JOUR
TI  - Synergistic RNA therapy for scar reduction: co-delivery mRNA and siRNA attenuates MDA5/RIG-I activation to enhance anti-fibrotic efficacy.
AU  - Wang L
AU  - Yuan H
AU  - Mou Y
AU  - Zhang K
AU  - Zhou T
AU  - Huang X
PY  - 2026
JO  - Journal of controlled release : official journal of the Controlled Release Society
DO  - 10.1016/j.jconrel.2026.115347
UR  - https://doi.org/10.1016/j.jconrel.2026.115347
ER  - 

APA

L, W., H, Y., Y, M., K, Z., T, Z., & X, H. (2026). Synergistic RNA therapy for scar reduction: co-delivery mRNA and siRNA attenuates MDA5/RIG-I activation to enhance anti-fibrotic efficacy.. Journal of controlled release : official journal of the Controlled Release Society. https://doi.org/10.1016/j.jconrel.2026.115347

Source records